Legal Backgrounders

May 14, 2004

Legal Backgrounders

Debate Over “Generic Biologics” Poses Unique Challenges For Policy Makers

Download the PDF

By Alvin J. Lorman, a partner in the Washington, D.C. office of the global law firm of Mayer, Brown, Rowe & Maw LLP.

Related Content

Legal Backgrounders

March 19, 2004

Better Late Than Sorry: Medicare Reform Ushers In New Rules On Generic Drugs

By <a href="http://www.ropesgray.com/bios/bio_detail.aspx?SectionID=2&AttorneyID=000111903003" Alan R. Bennett, a partner with the law firm of Ropes & Gray LLP in the firm's Washington, D.C. office and <a href="http://www.ropesgray.com/bios/bio_detail.aspx?SectionID=2&AttorneyID=000113837421" X. Joanna Wu, Ph.D., an associate with the law firm in the Boston office.

Legal Backgrounders

December 6, 2002

Biting The Hand That Feeds?: Generic Drugs And Abuse Of The Hatch-Waxman Law

Robert D. Bajefsky and Gregory Chopskie of the intellectual property law firm Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., examine several court rulings which implicate generic drug makers in actions designed to seek advantage in the complex process of copying and marketing prescription drugs once their patent protection expires.